John Bouros CEO and founder of Alvion Pharmaceuticals in Greece on the opportunities inherent in any economic crisis, the growth of the Greek generics segment, and his strategy for growth; both domestic and international.
Can you please start by telling us how your originally came to found Alvion back in 2013 right at the height of the drama of the Greek economic crisis?
"It’s important to remember that economic crises are great moments to be making acquisitions because the valuation of companies tend to be at their lowest."
